These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2. Wang J; Xu Y; Xu Y; Zhu H; Zhang R; Zhang G; Li S Cancer Invest; 2008 May; 26(4):359-68. PubMed ID: 18443956 [TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic activity of the purine analog 6-thioguanine. Presta M; Belleri M; Vacca A; Ribatti D Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690 [TBL] [Abstract][Full Text] [Related]
29. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells. Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817 [TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. Murata M; Kador PF; Sato S J Ocul Pharmacol Ther; 2000 Aug; 16(4):383-91. PubMed ID: 10977134 [TBL] [Abstract][Full Text] [Related]
31. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype. Ortéga N; Jonca F; Vincent S; Favard C; Ruchoux MM; Plouët J Am J Pathol; 1997 Nov; 151(5):1215-24. PubMed ID: 9358746 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells. Wild R; Dhanabal M; Olson TA; Ramakrishnan S Br J Cancer; 2000 Oct; 83(8):1077-83. PubMed ID: 10993657 [TBL] [Abstract][Full Text] [Related]
33. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Lobov IB; Brooks PC; Lang RA Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11205-10. PubMed ID: 12163646 [TBL] [Abstract][Full Text] [Related]
35. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Wood JM Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930 [TBL] [Abstract][Full Text] [Related]
37. Dissociation between the Ca(2+) signal and tube formation induced by vascular endothelial growth factor in bovine aortic endothelial cells. Kawasaki J; Hirano K; Hirano M; Nishimura J; Nakatsuka A; Fujishima M; Kanaide H Eur J Pharmacol; 2000 Jun; 398(1):19-29. PubMed ID: 10856444 [TBL] [Abstract][Full Text] [Related]
38. Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis. Russell KS; Stern DF; Polverini PJ; Bender JR Am J Physiol; 1999 Dec; 277(6):H2205-11. PubMed ID: 10600838 [TBL] [Abstract][Full Text] [Related]
39. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Hirata A; Ogawa S; Kometani T; Kuwano T; Naito S; Kuwano M; Ono M Cancer Res; 2002 May; 62(9):2554-60. PubMed ID: 11980649 [TBL] [Abstract][Full Text] [Related]